Global Synthetic Biology Market to Reach $52.04 Billion by 2028 at a CAGR of 27.89%

DUBLIN, Nov. 17, 2022 /PRNewswire/ -- The "Global Synthetic Biology Market, By Products, By Application, By Tool, By Technology & By Region- Forecast and Analysis 2022-28" report has been added to  ResearchAndMarkets.com's offering.

The Global Synthetic Biology Market is valued at USD 9.3 Billion in 2021, and it is anticipated to attain a value of USD 52.04 Billion by 2028, at a CAGR of 27.89 % over the forecast period (2022 - 2028).

The interdisciplinary field of synthetic biology deals with the application of engineering concepts to biology. Its fundamental objective is to design and develop such biological components and systems that do not already exist in the natural world, which is a relatively young endeavour in comparison to other disciplines of Science and Technology. Researchers combine a chemical synthesis of DNA with improvements in their understanding of genomics to ensure the quick manufacture of altered DNA sequences and their integration into two genomes. Synthetic biology has the potential to provide solutions to issues in agriculture, manufacturing, and medicine.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Synthetic Technology Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The Global Synthetic Technology Market is segmented based on Product, Application, Tool, Technology, and Region. Based on Product it is categorized into: Core Products, Enabling Products, Enabled Products. Based on application it is categorized into Healthcare, Chemicals (Including Bio-fuels), Food, Agriculture, Other Applications (Biosecurity, Energy, Environment). Based on the tool it is categorized into Oligonucleotides, Synthetic Dna, Enzymes, Cloning Technologies Kits, Synthetic Cells, Chassis Organisms, Xeno-nucleic Acids. Based on the technology it is categorized into Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Site-directed Mutagenesis, Cloning, Measurement, Modeling, Microfluidics, Nanotechnology. Based on the region it is categorized into: North America, Europe, Asia-Pacific, South America, and MEA.

Drivers

The R&D industry has always required a lot of capital because of the extensive research and regulatory processes. R&D is viewed by governments as a crucial investment for a nation's wealth, global competitiveness, and public good. As a result, financing and investment in R&D have grown continuously over time. Investment in R&D in the life sciences industry increased by 22% between 2018 and 2019. Pharmaceutical and biotechnology companies invest a lot of money in research to create revolutionary new drugs to treat new diseases and meet the growing demands of the healthcare industry. Over 80% of all research and development expenditures in the life sciences sector are made by the global pharmaceutical business.

Restraints

The purposeful or unintended release of synthetic organisms into the environment during research and other uses is a major biosafety risk in synthetic biology. When synthetic bacteria are put into the environment, they might mutate or interact with other species, leading in crossbreeding and bio errors.

Market Trends

This industry is growing as a result of the biotechnological and pharmaceutical industries' growing need for synthetic biology for research and development purposes. The global synthetic biology market is being driven by the application of synthetic biology techniques in medication discovery and development.

Companies Mentioned

• Thermo Fisher Scientific, Inc. (US)
• Merck KGaA (Germany)
• Agilent Technologies, Inc. (US)
• Novozymes A/S (Denmark)
• Ginkgo Bioworks (US)
• Amyris (US)
• Precigen, Inc. (US)
• GenScript (China)
• Twist Bioscience (US)
• Synthetic Genomics (US)

For more information about this report visit https://www.researchandmarkets.com/r/1i2t96

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets